John Paul Aboubechara, MD, PHD
Neurology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Aboubechara’s office at (650) 498-6000 to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$3,782
Pharmacies billed $3,782 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 71) in 2024. At or below the middle of the specialty; the typical student in an organized health care education/training program clinician is at 0%.
66 generic and fewer than 11 brand-name prescriptions · $3,782 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Carbidopa-Levodopa | 21 | $219 | $10 |
Year by year
| 2024 | 71 | 20 | 0% (0) | None | $3,782 |
| 2023 | 45 | 16 | 0% (0) | None | $2,780 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$125 in 2025
A payment is not proof that care is biased.
| Argenx US | Vyvgart Hytrulo | $125 | 1 payment
|
See the published payment
| Argenx US | Meals · 2025-04-07 | Vyvgart Hytrulo | $125 |
Professional record
- NPI
- 1205461803
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 875 Blake Wilbur Dr, Palo Alto, CA, 94304
- NPI first listed
- 2020-03-04
- NPI last updated
- 2026-06-14
- NPI record certified
- 2026-06-14
This is when the NPI record was last certified, not a medical board exam.